Extracellular Modulation of Multiprotein Signalling Complexes: Molecular Regulation of FGFR Signalling by Anosmin & Heparan Sulphate Proteoglycans

多蛋白信号传导复合物的细胞外调节：Anosmin 对 FGFR 信号传导的分子调节

• 批准号: BB/F006616/1
• 负责人: Jeremy Turnbull
• 金额: $ 40.76万
• 依托单位: University of Liverpool
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2008
• 资助国家: 英国
• 起止时间: 2008 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=BB%2FF006616%2F1
• 关键词: Extracellular; Modulation; Multiprotein; Signalling; Complexes

Defects of a recently discovered protein called anosmin-1, or of a signaling protein called fibroblast growth factor receptor 1 (FGFR1), cause Kallmann's syndrome, an inherited human disorder resulting from abnormal development of neurons involved in smell and hormone-releasing functions. We recently discovered that anosmin-1 functions through interactions with FGFR1 signalling complexes that involve binding to a complex polysaccharide called heparan sulphate (HS), resulting in amplified responses. Our data provide the first evidence for anosmin-1 acting as a specific modulator of FGFR1 signalling and reveal a defined molecular mechanism linking the 2 genetic forms of Kallmans syndrome. In this project we are planning to characterize in more detail the molecular mechanisms of HS-dependent regulation of FGFR signalling by anosmin-1. We will use a variety of molecular, cell and structural biology techniques to examine the functional interactions between these molecules. These studies will provide insights into the regulation of multiprotein complexes involved in receptor signalling processes. The results will extend our understanding of the molecular mechanisms for the normal function of anosmin-1 and HS in FGFR signalling during human nervous system development, as well as in abnormal development in Kallmann's syndrome. This work could help to identify new targets for treating this syndrome, and also underpin the development of novel applications in tissue engineering and nerve regeneration.

最近发现的一种称为anosmin-1的蛋白质或称为成纤维细胞生长因子受体1（FGFR 1）的信号蛋白的缺陷会导致卡尔曼综合征，这是一种遗传性人类疾病，由参与嗅觉和嗅觉释放功能的神经元发育异常引起。我们最近发现，anosmin-1通过与FGFR 1信号复合物相互作用发挥作用，该复合物涉及与称为硫酸乙酰肝素（HS）的复杂多糖结合，导致反应放大。我们的数据提供了第一个证据，证明anosmin-1是FGFR 1信号传导的特异性调节剂，并揭示了一个明确的分子机制，将Kallmans综合征的2种遗传形式联系起来。在这个项目中，我们计划更详细地描述HS依赖性调节FGFR信号传导的anosmin-1的分子机制。我们将使用各种分子，细胞和结构生物学技术来研究这些分子之间的功能相互作用。这些研究将为参与受体信号传导过程的多蛋白复合物的调节提供见解。这些结果将扩展我们对anosmin-1和HS在人类神经系统发育过程中FGFR信号传导的正常功能以及Kallmann综合征异常发育的分子机制的理解。这项工作可以帮助确定治疗这种综合征的新靶点，并支持组织工程和神经再生新应用的发展。